By Dani Kass (December 21, 2023, 10:54 PM EST) — The Federal Trade Commission’s push to stop drugmakers from artificially extending their exclusivity period by misusing a U.S. Food and Drug Administration database has resulted in GlaxoSmithKline, Kaleo and Impax Laboratories requesting nearly all questioned patents be delisted….
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.law360.com/ip/articles/1779946?utm_source=rss&utm_medium=rss&utm_campaign=section